 |
||||||||||||||||||||
|
|
|
||||||||||||||||||
| Drugs 2011; 71 (3): 263-271 Drugs in Development for Viral Hepatitis, Care and Caution. Pockros, Paul J. VIEW DOWNLOAD Therapeutic Advances in Gastroenterology 2010; 3 (3). 191-202. New direct-acting antivirals in the development for hepatitis C virus infection. Pockros, Paul J. VIEW DOWNLOAD Hepatology, Vol. 50, No. 3, 2009, 717-726. A Phase III Study of the Safety and Efficacy of Viramidine Versus Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C: ViSER1 Results. Benhamou Y, Afdhal N, Nelson DR, Shiffman ML, Halliman DG, Heise J, Chun E, Pockros, Paul J VIEW DOWNLOAD Clinical Liver Disease 13. (2009) 419-427. Ribavirin Analogs. Shields, William W., Pockros, Paul J VIEW DOWNLOAD Clinical Liver Disease 13. (2009) 365-373. Antifibrotics for Chronic Hepatitis C. Pockros, Paul J. VIEW DOWNLOAD Journal of Hepatology 47. (2007) 174-182. Oral resiquimod in chronic HCB infection: Safey and efficacy in 2 placebo-controlled, double-blind phase IIa studies. Pockros PJ, Guyader D, Patton H, Tong M, Wright T, McHutchison JG, Meng T. VIEW DOWNLOAD Hepatology, Vol. 46, No. 2. 2007. Oral IDN-6556 an Antiapoptotic Caspase Inhibitor May Lower Aminotransferase Activity in Patients with Chronic Hepatitis C. Pockros PJ, Schiff ER, Shiffman ML, McHutchison JG, Gish RG, Afdhal NH, Makhviladze M, Huyghe M, Hecht D, Oltersdorf T, Shapiro D. VIEW DOWNLOAD Hepatology, Vol 45, No. 3. 2007. Final Results of A Double-Blind Placebo-Controlled Trial of the Antifibrotic Efficacy of Interferon-γ1b in Chronic Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. Pockros PJ, Jeffers L, Afdhal N, Goodman ZD, Nelson D, Gish RG, Reddy KR, Reindollar R, Rodriguez-Torres M, Sullivan S, Blatt LM, Faris-Young S. VIEW DOWNLOAD |
Gastroenterology, 2004:126:1302-1311. Epoetin Alfa Maintains Ribavirin Dose in HCV-Infected Patients: A prospective, Double-Blind, Randomized Controlled Study. Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ, and the Proactive Study Group. VIEW DOWNLOAD Hepatology, Vol. 40, No. 6. 2004. Epoetin alfa Improves Quality of Life in Anemic HCV-Infected Paitents Receiving Combination Therapy. Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH, and the Proactive Study Group. VIEW DOWNLOAD Journal of Viral Hepatitis, 2003, 10, 55-60. The safety and tolerability of daily infergen plus ribavirin in the treatment of naive chronic hepatitis C Patients. Pockros PJ, Reindollar R, McHutchison J, Reddy R, Wright T, Boyd DG, Wilkes L. VIEW DOWNLOAD Hepatology, Vol. 37, No. 6, 2003. A Multicenter Study for Recombinant Human Interleukin 12 for the Treatment of Chronic Hepatitis C Virus Infection in Patients Nonresponsive to Previous Therapy. Pockros PJ, Patel K, O'Brien C, Tong M, Smith C, Rustgi V, Carithers RL, McHutchison JG, Olek E, DeBruin MF. VIEW DOWNLOAD Hepatology, Vol 26, No. 3, 1997, 747-754. Treatment of Chronic Hepatitis C With Consensus Interferon: A Multicenter, Randomized, Controlled Trial. Tong MJ, Reddy R, Lee WM, Pockros, Paul J, Hoefs JC, Keeffe EB, Hollinger FB, Hatchote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J, and the Consensus Interferon Study Group. VIEW DOWNLOAD |
|||||||||||||||||||
|
Copyright © 2011 SCLRC - SC Liver Research Consortium LLC All rights reserved 11025 North Torrey Pines Road, Suite 200, La Jolla CA 92037 1-877-415-9504 site created by THE CODE CREW |